Adicet Bio (ACET) Cash Flow Statement

Click line-items for a historical chart and %

Net income	4.39M
Depreciation and amortization	3.17M
Provision for doubtful accounts	-58K
Non-cash stock compensation	1.66M
Deferred income taxes	1.41M
Unrealized loss (gain) on trading securities
Earnings on equity investment in joint venture	-325K
Trade accounts receivable	9.14M
Other receivables	464K
Inventory	-6.11M
Prepaid expenses and other current assets
Other assets	-305K
Accounts payable	3.14M
Accrued expenses and other liabilities	-6.54M
Net cash provided by operating activities
Purchases of investments	-1.02M
Maturities of investments
Payments received on notes receivable
Purchases of property and equipment, net	-541K
Payments for intangible assets	-1.59M
Net cash provided by (used in) investing activities
Proceeds from exercise of stock options	185K
Excess tax benefit on stock option exercises and restricted stock	437K
Repayment of bank loans	-49K
Borrowings of bank loans	0
Net cash (used in) provided by financing activities
Effect of exchange rate changes on cash	197K
Net increase in cash	6.31M
Cash at beginning of period	66.83M
Cash at end of period	73.14M

Entities mentioned with ACET

View All Entities